CARITI, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 331
EU - Europa 107
AS - Asia 49
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
SA - Sud America 2
OC - Oceania 1
Totale 495
Nazione #
US - Stati Uniti d'America 329
IT - Italia 40
IE - Irlanda 29
CN - Cina 21
SE - Svezia 19
IN - India 7
JP - Giappone 7
SG - Singapore 5
FR - Francia 4
EU - Europa 3
GB - Regno Unito 3
MY - Malesia 3
VN - Vietnam 3
BE - Belgio 2
CA - Canada 2
CO - Colombia 2
DE - Germania 2
FI - Finlandia 2
NG - Nigeria 2
UA - Ucraina 2
ES - Italia 1
HK - Hong Kong 1
KR - Corea 1
MK - Macedonia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RU - Federazione Russa 1
Totale 495
Città #
Chandler 92
Dublin 29
Ann Arbor 21
Ashburn 19
Nyköping 14
Medford 10
Princeton 10
Beijing 7
Boston 7
Pescara 7
Hebei 6
Milan 6
Singapore 5
Jacksonville 4
Pune 4
Torino 4
Washington 4
Norwalk 3
Wilmington 3
Abuja 2
Bogotá 2
Bologna 2
Brussels 2
Esslingen am Neckar 2
Florence 2
Guiyang 2
Hangzhou 2
Lappeenranta 2
Modena 2
New York 2
Nottingham 2
Putrajaya 2
Arcene 1
Auckland 1
Barcelona 1
Bourne 1
Cambridge 1
Cattolica 1
Central District 1
Chengdu 1
Dong Ket 1
Fagnano Olona 1
Falls Church 1
Greenville 1
Guangzhou 1
Houston 1
Kajang 1
Kansas City 1
Kawasaki 1
Mountain View 1
Mumbai 1
Naples 1
Nijmegen 1
Québec 1
Redmond 1
Redwood City 1
Regina 1
Riverton 1
Rome 1
San Mateo 1
Seattle 1
Seoul 1
Shenyang 1
Turin 1
Totale 313
Nome #
Dual-targeted therapy with apremilast and vedolizumab in pyoderma gangrenosum associated with Crohn’s disease 61
Anogenital warts treatment options: a pratical approach 55
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? 50
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients 49
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study 46
Infections in Sézary syndrome: A retrospective cohort study of 113 patients 45
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience 43
Sezary syndrome: A single center retrospective study with proposal for a clinical score system 36
Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient 30
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis 28
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents 19
Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients 13
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks 12
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors 10
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement 9
Mask-related acne flares during the COVID era 7
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients 6
Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study 4
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real-life experience on 638 patients with psoriasis 2
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment 1
Drug survival und klinische Wirksamkeit von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab und Tildrakizumab in der Behandlung der Psoriasis: Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment 1
Totale 527
Categoria #
all - tutte 2.870
article - articoli 0
book - libri 0
conference - conferenze 172
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 1 0 0 1 0 0 0 1 1 2 4 9
2020/202114 4 2 2 1 1 0 0 0 0 0 1 3
2021/2022134 6 0 3 3 16 10 13 16 5 4 25 33
2022/2023233 17 28 4 21 19 43 13 20 29 4 17 18
2023/2024123 15 29 13 13 8 20 7 4 2 12 0 0
Totale 527